NINE SQUARE THERAPEUTICS
Nine Square Therapeutics is discovering new small-molecule therapeutics for degenerative movement disorders including Parkinsonโs disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative disorders such as essential tremor and dyskinesias, by integrating computational chemistry, biophysics, and computational biology into machine-learning-enabled cell profiling platforms for target identification, chemical optimization, and patient stratification. It was founded in 2020 and headquartered in New York, United States.
NINE SQUARE THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ninesquaretx.com
Total Employee:
101+
Status:
Active
Total Funding:
50 M USD
Current Advisors List
Current Employees Featured
Founder
Investors List
Apple Tree Partners
Apple Tree Partners investment in Series A - Nine Square Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-01-11 | Nine Square Therapeutics Appoints Robert Paul as CEO |
Official Site Inspections
http://www.ninesquaretx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nine Square Therapeutics"
Innovation-driven. Patient-inspired. - Nine Square Therapeutics
Accelerating the development of better drugs for better targets in a quest to alter the trajectory of neurodegenerative disease. Inquisitive by nature, we go after solutions beyond the ordinary. โฆSee details»
About Us - Nine Square Therapeutics
We are boosting autophagy to address genetically validated, but previously undruggable targets with the goal of overcoming the historical challenges of treating severe neurodegenerative diseases. Nine Square was founded by life โฆSee details»
Nine Square Therapeutics - LinkedIn
Founded by life sciences venture capital firm ATP and renowned scientists at the University of California San Francisco (UCSF), Nine Square is uniting machine learning-enabled image-based cell...See details»
Nine Square Therapeutics - Crunchbase Company Profile & Funding
Nine Square Therapeutics is a developer of novel therapies for movement disorders. Nine Square Therapeutics may be growing as it has recently received a significant financial award to โฆSee details»
Nine Square Therapeutics Appoints Robert Paul as CEO โฆ
Jan 11, 2022ย ยท Nine Square Therapeutics, an ATP company based in South San Francisco, is discovering novel small-molecule therapeutics for Parkinson's disease, amyotrophic lateral sclerosis (ALS) and...See details»
Nine Square Therapeutics Appoints John Hood to โฆ
Sep 13, 2022ย ยท SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 /PRNewswire/ -- Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to...See details»
Nine Square Therapeutics Appoints Robert Paul as CEO
Jan 11, 2022ย ยท Nine Square Therapeutics, an ATP company based in South San Francisco, is discovering novel small-molecule therapeutics for Parkinson's disease, amyotrophic lateral โฆSee details»
Science - Nine Square Therapeutics
Nine Square is developing compounds that activate autophagy pathways to enhance clearance of aggregated proteins and lipids, remove damaged mitochondria, and restore cellular homeostasis to mitigate neurodegeneration.See details»
Nine Square Therapeutics Awarded $4.5 Million Grant ... - Business โฆ
Sep 12, 2023ย ยท SAN FRANCISCO-- (BUSINESS WIRE)--Nine Square Therapeutics, a biotechnology company discovering novel small molecules to treat severe neurodegenerative โฆSee details»
Nine Square Therapeutics Awarded $4.5 Million Grant from The โฆ
San Francisco โ September 12, 2023 โ Nine Square Therapeutics, a biotechnology company discovering novel small molecules to treat severe neurodegenerative diseases, today โฆSee details»
Nine Square Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Nine Square, a biotechnology company discovering novel small molecules to treat severe neurodegenerative diseases, said that the grant will contribute to accelerating the identification โฆSee details»
Nine Square Therapeutics - Overview, News & Similar ... - ZoomInfo
Jan 10, 2022ย ยท View Nine Square Therapeutics (www.ninesquaretx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well โฆSee details»
Apple Tree Partners | Nine Square Therapeutics Awarded...
Sep 12, 2023ย ยท Nine Square is building a diversified portfolio of first-in-class drug candidates for genetically validated targets along the autophagy/lysosomal pathway. The company has โฆSee details»
Nine Square Therapeutics Appoints Robert Paul as CEO
Jan 11, 2022ย ยท Nine Square Therapeutics, an ATP company based in South San Francisco, is discovering novel small-molecule therapeutics for Parkinson's disease, amyotrophic lateral โฆSee details»
Nine Square Therapeutics CEO and Key Executive Team - Craft
Nine Square Therapeutics's key executives include Mark Rosen and 6 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on โฆSee details»
Apple Tree Partners | Nine Square Therapeutics Appoint...
SOUTH SAN FRANCISCO, CA/January 11, 2021 โ Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to โฆSee details»
Nine Square Therapeutics - Craft
Nine Square Therapeutics has 5 employees at their 1 location. See insights on Nine Square Therapeutics including office locations, competitors, revenue, financials, executives, โฆSee details»
Apple Tree Partners | Nine Square Therapeutics Appoint...
Sep 13, 2022ย ยท Nine Square Therapeutics is discovering novel small-molecule therapeutics for life-threatening neurodegenerative diseases, such as Parkinson's disease and ALS.See details»
Nine Square Therapeutics, Inc. (Nine Square Therapeutics, Inc.)
Nine Square, a biotechnology company discovering novel small molecules to treat severe neurodegenerative diseases, said that the grant will contribute to accelerating the identification โฆSee details»
Nine Square Therapeutics Appoints John Hood to Board of Directors
Nine Square Therapeutics is discovering novel small-molecule therapeutics for life-threatening neurodegenerative diseases, such as Parkinsonโs disease and ALS.See details»